Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Boston Scientific has recently reported the results of the Optical Coherence Tomography Drug Eluting Stent Investigation (OCTDESI)trial; part of the JACTAX stent program. [30] The JACTAX stent con ...

You will be redirected to our submission process. Drug-eluting balloons (DEBs) represent a significant advancement in the field of interventional cardiology, offering an innovative approach to treat ...

This summary highlights recent research on automated insulin delivery systems and drug-eluting stents, showcasing their effectiveness and the ongoing efforts to optimize their use in clinical ...

Interventional Cardiology Devices Market size is expected to be worth around USD 38 Billion by 2032 from USD 19 Billion in 2023, growing at a CAGR of 8.0% Lawrence John Prudour +91 91308 55334 ...

The following is a summary of “Effectiveness and Safety of Ticagrelor Monotherapy After Short-Duration Dual Antiplatelet ...

Bentley’s BeFlow Covered Stent for Iliac Occlusive Diseases Launched in Europe January 28 ... recently announced that it received WCG institutional review board (IRB) approval for the ELITE-BTK ...

Technological improvements, such as bioresorbable stents, drug-eluting stents, bioresorbable occluder and imaging systems, are significantly enhancing procedural efficacy and patient outcomes, making ...

Moreover, advancements in stent technology have led to the development of drug-eluting stents, which are designed to minimize complications such as granulation tissue formation that can lead to ...